So my post about the Abbott test was off. The accuracy is actually quite good. The real remaining hole is that it is only for symptomatic people. So if someone has recently acquired CV or is one of the many who never shows symptoms, they can’t use that test.
At least that’s what the CEO just said on CNBC...
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links